Target intelligence / Profile preview

Clathrin interactor 1 (CLINT1)

Target
CLINT1
Molecular classification
Other (clathrin-interacting ENTH domain protein, adaptor protein, endocytosis-related)
01

Overview

Clathrin interactor 1 (CLINT1) is a protein containing an ENTH domain involved in clathrin-mediated trafficking at the trans-Golgi network and endosomes, functioning as an adaptor protein for the formation and maturation of clathrin-coated vesicles[1][4][3]. CLINT1 interacts with clathrin, AP-1 adaptor protein, SNARE proteins, phosphoinositides, and other trafficking proteins, promoting vesicle assembly and cargo selection, and is structurally related to the epsin protein family[1][2][3][4]. CLINT1 plays a key role in intracellular trafficking and homeostasis; its dysfunction is implicated in susceptibility to schizophrenia and other psychiatric conditions in humans[1][3][4], is regulated by miR-145 in bladder cancer[1], and is essential for epidermal development in animal models, with loss leading to inflammation and skin barrier defects resembling psoriasis[2]. No direct pharmacological modifiers or clinical biomarkers are presently reported.

Other names
Epsin-4Epsin-related proteinEPSINREPN4ENTHEPNRKIAA0171EnthoprotinClathrin-interacting protein localized in the trans-Golgi regionAI642036C530049I24RIKF630206G17RikLOC100131045
02

Biological functions

Clathrin-mediated traffickingVesicle formation and maturationEndocytosisCargo selectionProtein transport between the trans-Golgi network and endosomesEpidermal developmentRegulation of cell homeostasis
03

Disease associations

SchizophreniaPsychotic disordersPotential cancer role (e.g., regulation by miR-145 in bladder cancer)Epidermal proliferation/inflammation (zebrafish model, psoriasis-like skin changes)

Beyond the preview

Go deeper on Clathrin interactor 1 (CLINT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clathrin interactor 1 (CLINT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call